Creative Biolabs-Lipid Based Drug Delivery

Ethosomes

Drug delivery by vesicular system has overtaken the pre-existing drugs by improving therapeutic efficacy and by sustaining and controlling action. Ethosomes are novel carrier systems used for delivery of drugs possessing low penetration through the biological membrane, mainly skin. With years of experience and high-end technologies in dermal and transdermal drug delivery research, Creative Biolabs has successfully developed a series of innovative and diversified lipid-based drug delivery platforms to provide fast and convenient services for our worldwide customers. Now, we provide high-quality no matter individual ethosomes development services and commercial ethosomes products for our clients to help your project make great progress.

Ethosomes

Ethosomal drug delivery system is non-invasive and delivers the drug to the deep skin layers to the systemic circulation. They are soft, malleable vesicles composed mainly of phospholipids such as phosphatidylserine, phosphatidylcholine, ethanol (relatively high concentration) and water, possessing a wide range of sizes from tens of nanometres to microns. Drug delivery can be modulated by altering alcohol:water ratio. In detail, some preferred phospholipids are soya phospholipids and high concentration of alcohol (20-45%) in the formulation provides soft, flexible characteristics and stability to the vesicles and it also disrupts lipid bilayer structure of the skin results in an increase in the membrane permeability.

Fig.1 Schematic representation of the different types of lipid-based vesicular delivery systems. (Hua, Susan, 2014)Fig.1 Schematic representation of the different types of lipid-based vesicular delivery systems.1,2

Therapeutic application

Ethosomes are able to penetrate the deeper layers of the skin and hence appear to be vesicles of choice for transdermal drug delivery of hydrophilic and impermeable drugs through the skin. Ethosomes are regarded as a non-invasive type of carriers that deliver drugs to deep skin layers and/or systemic circulation. Ethosomes are sophisticated, safe, and effective systems and easily prepared. Once any moiety is entrapped within the system, it is not exposed to metabolic degradation and dilution. These types of systems have a prolonged drug release improving the therapeutic benefit. Nowadays, ethosomes is widely used in the delivery of protein, DNA and other bioactive agents for the treatment of herpetic infection, AIDS, parkinsonian syndrome, diabetes and so forth.

What We Can Do for You?

Aided by our well-established platforms and experienced scientists, we can provide comprehensive ethosomes services, varying from lipid-based drug delivery characterization, delivery system construction services to in vitro efficacy validation, in vivo PK/PD validation. A wide spectrum of customized delivery products is available for your choice.

Advantages of Our Ethosomes System

  • Enhanced permeation of drug molecules to and through the skin to the systemic circulation
  • Improved skin delivery of drugs both under occlusive and non-occlusive conditions
  • Better patient compliance
  • Better solubility and stability of many drugs
  • Relatively smaller size
  • Did not exhibit any toxicity

With expertise and dedication, advanced ethosomes design platforms and services from Creative Biolabs will be your best companion in preparing customized ethosomes. Please contact us for more information and a detailed quote.

References

  1. Hua, Susan. "Lipid-based nano-delivery systems for skin delivery of drugs and bioactives." Frontiers in pharmacology 6 (2015): 219.
  2. under Open Access license CC BY 4.0, without modification.
For Research Use Only. Not For Clinical Use

Supports

Formulation Science Background of Liposome Research Highlights
Resources Technical Supports Featured Services Knowledge Center
Optimizing LNP Molar Ratios for Transfection Efficiency
Scalability Challenges in mRNA-LNP Manufacturing
Beyond mRNA: LNP Delivery for CRISPR/Cas9
Cationic Lipids Evolution: DOTAP to Ionizable Lipids
LNP Storage Stability: Lyophilization vs. Liquid
Modulating LNP Biodistribution: Overcoming Liver Accumulation
Active vs. Passive Targeting (EPR): A Guide to Tumor Drug Delivery
Immunoliposomes: Comparing Pre-insertion vs. Post-insertion Techniques
Crossing the BBB: Advances in Transferrin and Peptide-Modified Liposomes
pH-Responsive Liposomes for Tumor Microenvironment
Thermosensitive Liposomes combined with HIFU
Aptamer-Modified Liposomes: A Cost-Effective Antibody Alternative
Ethosomes vs Transfersomes for Dermal Delivery
Strategies for Encapsulating Poorly Water-Soluble Small Molecules in Liposomes
Multivesicular Liposomes: The Architecture of Sustained Release
Mechanisms of Liposomal Adjuvants in Enhancing Vaccine Immune Response
Protecting Enzymatic Activity: Liposomal Encapsulation Strategies for Enzymes
Cryo-TEM vs. DLS: Interpreting Discrepancies in Liposome Particle Size Data
Validating In Vitro Release Methods: Dialysis vs. Sample Separation Techniques
Predicting Long-Term Stability of Liposomal Suspensions using Zeta Potential
Troubleshooting Low Liposome Encapsulation Efficiency
Application of Multi-omics Analysis in Liposome Toxicology Assessment
The Ultimate Guide to Liposome Preparation
Fluorescent Liposomes for Cellular Uptake: Labeling, Controls, and Troubleshooting
How to Design Stealth Liposomes for Long Circulation
Homemade vs. Commercial Kits: Why Standardization Matters in Liposome Research

Online Inquiry